Login Register Cart 0
Generic placeholder image

Anti-Infective Agents

Editor-in-Chief

ISSN (Print): 2211-3525
ISSN (Online): 2211-3533

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Anticancer, Antidiabetic and Antimicrobial Activity Study of Biologically Active Vanadium(IV) Mixed Ligand Complexes

Author(s): Sonaji Vishwanath Gayakwad, Dnyaneshwar Shamrao Wankhede*, Vikas Dattarao Ragole, Shivraj Gangadhar Wanale, Satish Ashruba Dake and Satish Bapurao Maulage

Volume 21, Issue 4, 2023

Published on: 07 August, 2023

Article ID: e010623217541 Pages: 16

DOI: 10.2174/2211352521666230601112815

Price: $65

Abstract

Introduction: Cancer and diabetes are proving to be lethal to human society and have attracted attention of researchers around the world. Synthesis of mixed ligand complexes is a challenging area owing to their potential applications as drugs against various diseases.

Methods: Synthesis and biological evaluation of mixed ligand complexes of Vanadium(IV) with heterocyclic bidentate molecule 8-hydroxyquinoline as primary ligand and L-Amino acids such as L-cysteine, L-alanine, L-phenylalanine, L-threonine and L-serine as secondary ligands is reported here. All the complexes were characterized using IR, electronic, Mass, TGA/DTA method, powder XRD analysis, molar conductance and magnetic susceptibility measurements and were screened for their biological activities.

Results: The synthesized mixed ligand complexes were screened for their antibacterial activity against E. coli and antifungal activity against C. albicans. They were also evaluated for in vitro antidibetic activity, anticancer activity against HepG2 (human liver cancer cell line) by MTT assay.

Conclusion: The synthesized mixed ligand complexes were thermally stable, paramagnetic, nonelectrolytic in nature and proposed to have square pyramidal geometry. They also exhibited potential as antibacterial, anticancer and antidibetic agents.

Keywords: Anticancer, Antidibetic, α-amylase, Powder XRD, HePG2, Square pyramidal.

Graphical Abstract

[1]
Jevtović, V.; Ivković, S.; Kaisarević, S.; Kovačević, R. Anticancer activity of new copper(II) complexes incorporating a pyridoxal-semicarbazone ligand. Contemp. Mater., 2010, 1(2), 133-137.
[http://dx.doi.org/10.5767/anurs.cmat.100102.en.133J]
[2]
Zhang, H.; Yuetao, Y.; Dawei, F.; Yipeng, W.; Song, Q. Hypoglycemic properties of Oxovanadium (IV) coordination compounds with carboxymethyl-carrageenan and carboxymethyl-chitosan in alloxan-induced diabetic mice. Evid. Based Complement. Alternat. Med., 2011, 2011, 691067.
[http://dx.doi.org/10.1155/2011/691067]
[3]
Mariappan, G.; Saha, B.P.; Datta, S.; Kumar, D.; Haldar, P.K. Design, synthesis and antidibetic evaluation of oxazolone derivatives. J. Chem. Sci., 2011, 123(3), 335-341.
[http://dx.doi.org/10.1007/s12039-011-0079-2]
[4]
Shukla, S.N.; Gaur, P.; Jhariya, S.; Chaurasia, B.; Vaidya, P.; Dehariya, D.; Azam, M. Synthesis, characterization, in vitro anti-diabetic, anti-bacterial and anticorrosive activity of some Cr(III) complexes of schiff bases derived from isoniazid. Chem. Sci. Trans., 2018, 7(3), 424-444.
[http://dx.doi.org/10.7598/cst2018.1509]
[5]
Mukherjee, B.; Patra, B.; Mahapatra, S.; Banerjee, P.; Tiwari, A.; Chatterjee, M. Vanadium—an element of atypical biological significance. Toxicol. Lett., 2004, 150(2), 135-143.
[http://dx.doi.org/10.1016/j.toxlet.2004.01.009] [PMID: 15093669]
[6]
Korbecki, J.; Baranowska-Bosiacka, I.; Gutowska, I.; Chlubek, D. Biochemical and medical importance of vanadium compounds. Acta Biochim. Pol., 2012, 59(2), 195-200.
[http://dx.doi.org/10.18388/abp.2012_2138] [PMID: 22693688]
[7]
Crans, D.C. Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds1This manuscript summarizes the presentation given at the symposium ‘Biological Aspects of Vanadium Chemistry — Chemistry, Biochemistry and Therapeutic Applications of Vanadium Compounds’ and recently communicated in original research articles. The original research articles describing the experimental details of this work are given in Refs: [1–51. J. Inorg. Biochem., 2000, 80(1-2), 123-131.
[http://dx.doi.org/10.1016/S0162-0134(00)00048-9] [PMID: 10885472]
[8]
Willsky, G.R.; Chi, L.H.; Godzala, M., III; Kostyniak, P.J.; Smee, J.J.; Trujillo, A.M.; Alfano, J.A.; Ding, W.; Hu, Z.; Crans, D.C. Anti-diabetic effects of a series of vanadium dipicolinate complexes in rats with streptozotocin-induced diabetes. Coord. Chem. Rev., 2011, 255(19-20), 2258-2269.
[http://dx.doi.org/10.1016/j.ccr.2011.06.015] [PMID: 23049138]
[9]
Yuan, C.; Lu, L.; Gao, X.; Wu, Y.; Guo, M.; Li, Y.; Fu, X.; Zhu, M. Ternary oxovanadium(IV) complexes of ONO-donor Schiff base and polypyridyl derivatives as protein tyrosine phosphatase inhibitors: Synthesis, characterization, and biological activities. J. Biol. Inorg. Chem., 2009, 14(6), 841-851.
[http://dx.doi.org/10.1007/s00775-009-0496-6] [PMID: 19290551]
[10]
Li, M.; Ding, W.; Smee, J.J.; Baruah, B.; Willsky, G.R.; Crans, D.C. Anti-diabetic effects of vanadium(III, IV, V)–chlorodipicolinate com-plexes in streptozotocin-induced diabetic rats. Biometals, 2009, 22(6), 895-905.
[http://dx.doi.org/10.1007/s10534-009-9241-4] [PMID: 19404749]
[11]
Fedorova, E.V.; Buryakina, A.V.; Zakharov, A.V.; Filimonov, D.A.; Lagunin, A.A.; Poroikov, V.V. Design, synthesis and pharmacological evaluation of novel vanadium-containing complexes as antidibetic agents. PLoS One, 2014, 9(7), e100386.
[http://dx.doi.org/10.1371/journal.pone.0100386] [PMID: 25057899]
[12]
Sanoja, W.; Martínez, J.D.; Araujo, M.L.; Brito, F.; Hernández, L.; Del Carpio, E.; Lubes, V. Stability constants of mixed ligand complexes of vanadium(III) with 8-hydroxyquinoline and the amino acids glycine, proline, α-alanine and β-alanine. J. Mol. Liq., 2014, 197, 223-225.
[http://dx.doi.org/10.1016/j.molliq.2014.05.012]
[13]
Sarmiento, L.E.; Rodríguez, M.; Echevarria, L.; Lubes, V. Speciation of the Vanadium(III) complexes with 1,10-phenanthroline, 2,2′-bipyridine, and 8-hydroxyquinoline. J. Solution Chem., 2010, 39(10), 1484-1491.
[http://dx.doi.org/10.1007/s10953-010-9603-0]
[14]
Patil, S.S.; Thakur, G.A.; Shaikh, M.M. Synthesis, characterization, and antibacterial studies of mixed ligand dioxouranium complexes with 8-hydroxyquinoline and some amino acids. ISRN Pharm., 2011, 2011, 168539.
[http://dx.doi.org/10.5402/2011/168539]
[15]
Vogel, A.I. Textbook of Practical Organic Chemistry, 5th ed; Longman: London, 1989.
[16]
Balouiri, M.; Sadiki, M.; Ibnsouda, S.K. Methods for in vitro evaluating antimicrobial activity: A review. J. Pharm. Anal., 2016, 6(2), 71-79.
[http://dx.doi.org/10.1016/j.jpha.2015.11.005] [PMID: 29403965]
[17]
Bernfeld, P. Amylases, α and β. Methods Enzymol., 1955, 1, 149-158.
[http://dx.doi.org/10.1016/0076-6879(55)01021-5]
[18]
Senthilraja, P.; Kathiresan, K. In vitro cytotoxicity MTT assay in Vero, HepG2 and MCF -7 cell lines study of Marine Yeast. J. Appl. Pharm. Sci., 2015, 5(3), 80-84.
[http://dx.doi.org/10.7324/JAPS.2015.50313]
[19]
Horiuchi, N.; Nakagawa, K.; Sasaki, Y.; Minato, K.; Fujiwara, Y.; Nezu, K.; Ohe, Y.; Saijo, N. In vitro antitumor activity of mitomycin C derivative (RM-49) and new anticancer antibiotics (FK973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay. Cancer Chemother. Pharmacol., 1988, 22(3), 246-250.
[http://dx.doi.org/10.1007/BF00273419] [PMID: 2842080]
[20]
Bodkhe, A.S.; Patil, S.S.; Shaikh, M.M. Synthesis, characterization and antibacterial studies on mixed ligand copper complexes with poly-dentate ligands. Acta Pol. Pharm., 2012, 69(5), 871-877.
[PMID: 23061283]
[21]
Wang, Y.; Lin, X.M.; Bai, F.Y.; Sun, L.X. Novel vanadium complexes with rigid carboxylate ligands: Synthesis, structure and catalytic bro-mine dynamics of phenol red. J. Mol. Struct., 2017, 1149, 379-386.
[http://dx.doi.org/10.1016/j.molstruc.2017.07.015]
[22]
Bajju, G.D.; Sharma, P.; Kapahi, A.; Bhagat, M.; Kundan, S.; Gupta, D. Oxovanadium(IV) complexes with nitrogen donors: Synthesis, char-acterisation, and biological activities. J. Inorg. Chem., 2013, 2013(3)
[http://dx.doi.org/10.1155/2013/982965]
[23]
Mishra, A.P.; Pandey, L.R.; Jain, R.K. Microwave synthesis, reactivity, spectral and thermal analysis of some binary/mixed ligand Oxo-vanadium(IV) complexes. Chem. Sci. Trans., 2012, 1(1), 121-133.
[http://dx.doi.org/10.7598/cst2012.135]
[24]
Shivankar, V.S.; Vaidya, R.B.; Dharwadkar, S.R.; Thakkar, N.V. Synthesis, characterization, and biological activity of mixed ligand Co(II) complexes of 8‐hydroxyquinoline and some amino acids. Synth. React. Inorg. Met.-Org. Chem., 2003, 33(9), 1597-1622.
[http://dx.doi.org/10.1081/SIM-120025443]
[25]
Tabassum, S.; Zaki, M.; Arjmand, F.; Ahmad, I. Synthesis of heterobimetallic complexes: In vitro DNA binding, cleavage and antimicrobial studies. J. Photochem. Photobiol. B, 2012, 114, 108-118.
[http://dx.doi.org/10.1016/j.jphotobiol.2012.05.017] [PMID: 22762922]
[26]
Hossain, A.; Islam, M.S.; Alam, A.; Sultan, T. Synthesis, physicochemical studies and antimicrobial screening of metal complexes Of Fe(III) & Au(III) with amino acids. Int. J. Sci. Techno. Res., 2013, 2(7), 210-217. [IJSTR].
[27]
Amolegbe, S.A.; Adewuyi, S.; Akinremi, C.A.; Adediji, J.F.; Lawal, A.; Atayese, A.O.; Obaleye, J.A. Iron(III) and copper(II) complexes bearing 8-quinolinol with amino-acids mixed ligands: Synthesis, characterization and antibacterial investigation. Arab. J. Chem., 2015, 8(5), 742-747.
[http://dx.doi.org/10.1016/j.arabjc.2014.11.040]

Rights & Permissions Print Cite
Article Metrics
21
1
© 2024 Bentham Science Publishers | Privacy Policy